Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
The companies had entered a collaboration at the end of last year, leveraging Ovations multi-omics and longitudinal clinical data and PrecisionLifes advanced analytics platform to uncover genetic mechanisms of response to GLP-1 medication
GLP-1RA inhibit endothelial cell dysfunction while attenuating abnormal migration, proliferation, and apoptosis in VSMCs
For enhanced effectiveness, GLP-1 therapy is integrated with personalized lifestyle modifications
US$ 25.08
US$ 28.22
US$ 25.57
US$ 27.95
US$ 25.84
